Benzinga | Jan 8, 2021 08:37AM EST

Avidity Biosciences Announces Research Collaboration With MyoKardia

Research Collaboration with MyoKardia, a Wholly-Owned Subsidiary of Bristol Myers Squibb

* Avidity has entered into a research collaboration with MyoKardia, a wholly-owned subsidiary of Bristol Myers Squibb, to demonstrate the potential utility of AOCs in cardiac tissue by leveraging MyoKardia's genetic cardiomyopathy platform including, among other aspects, its novel target discovery engine and proprietary cardiac disease models.